No new patients should begin treatment with ulipristal acetate for uterine fibroids, which will be temporarily suspended in Europe while a review of liver injury risk is ongoing, the agency advises.
News Alerts …read more
No new patients should begin treatment with ulipristal acetate for uterine fibroids, which will be temporarily suspended in Europe while a review of liver injury risk is ongoing, the agency advises.
News Alerts …read more